This content is from: Portfolio Here’s Why the Illiquidity Premium Is a Bad Reason to Invest in PE Investors go into private markets knowing they can’t easily sell their funds — an expectation that eliminates the compensation for tying up their money. By Julie Segal January 25, 2023
This content is from: Premium EJF Capital’s Nightmare Here’s how the financials-oriented firm is coping with the bank stock selloff. By Stephen Taub March 20, 2023
This content is from: Premium Seligman’s Wick Predicted the Tech Rally The manager who enjoyed a profitable 2022 singles out seven companies with low valuations. By Stephen Taub March 17, 2023
This content is from: Premium Institutional Investors More Than Doubled Their Hedge Fund Allocations Last Year Here’s a look at last year’s biggest allocators — and the top hedge fund recipients. By Stephen Taub March 21, 2023
This content is from: Premium Biopharma Funds Stumble in February But several funds may already be racking up big gains in March. By Stephen Taub March 16, 2023
This content is from: Portfolio ‘Factor Investing Is Finally Back’ Since most premiums are cheap today, Research Affliates’ Rob Arnott suggests investors take a multi-factor approach. By Hannah Zhang January 20, 2023
